Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
AOD 9604 is a synthetic 16-amino acid peptide fragment
Clinical Relevance and Human Trials Clinical trials have explored the administration of BPC 157 at a dosage of 200 g per person per day via intramuscular injection for a duration of 7 days
In addition, a general sense of tiredness can develop despite obtaining enough sleep, and memory loss and/or shortness of breath may begin to occur
BPC-157 is not FDA-approved for any medical condition, but it is legally available through licensed 503A compounding pharmacies with a provider prescription
Summary AOD-9604 is a compact, well-studied growth hormone fragment with a narrow lipolytic mechanism, a strong safety record in toxicology studies, and a clear position in metabolic research as a GH-receptor-independent tool compound
A syringe that is too small cannot hold the required volume
US$ 26.89
US$ 28.46
US$ 22.79
US$ 22.93
US$ 29.37
US$ 26.91
US$ 23.76
US$ 20.26
US$ 20.61
